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Little is known concerning the pathway of the crystallization of the thermodynamically stable polymorph of
theophylline, form IV. Here we study the reasons why the thermodynamically stable theophylline form IV
can be obtained only by slow, solvent mediated phase transformation (SMPT) in specific solvents, and
whether the presence of prenucleation aggregates affect the polymorphic outcome. Solution
concentration, polymorphic composition and morphology were monitored over time during the
transformation from form II to form IV in several solvents. NMR and FTIR spectroscopy were used to
detect prenucleation molecular aggregates present in the solutions. It was determined that theophylline
self-associates in solvents which are good H-bond donors and the presence of these aggregates hinder
the nucleation and phase transformation. SMPT from form II to form IV is a nucleation-growth controlled
polymorphic transformation, nucleation is most likely homogenous, and form IV crystals grow along the
(001) plane, forming plate-like crystals.1. Introduction
Polymorphism is a well-known phenomenon whereby a chemi-
cal compound may exist in more than one crystalline form, and
each of these forms displays different physical characteristics
such as density, melting point and solubility. Polymorphism is
of great importance in the pharmaceutical industry, because
these differences in physical properties among the polymorphs
can sometimes lead to apparent differences in drug processing,
formulation, and bioavailability. Therefore, it is a common
requirement in Pharmacopeia for active pharmaceutical ingredi-
ents to be produced in one fixed crystalline form, and for this
reason the thermodynamically stable form is generally preferred
for pharmaceutical production. However, a metastable poly-
morph may be preferred if the solubility and/or bioavailability
of the thermodynamically stable polymorph does not meet
required criteria.1–3 In such cases knowledge of the possible
phase transformation in a given polymorphic system is essential.
Theophylline – a methyl xanthine derivative (3,7 dihydro-1,3-
dimethyl-1H-purine-2,6-dione) is an example of a pharmaceutically
active compound that has been manufactured and used in ametastable crystalline phase (clearly, because of the lack of
comprehensive knowledge of the polymorphic landscape of
this compound) (Scheme 1). Theophylline is known to exist
in four polymorphic forms (I, II, III and IV), as a mono-
hydrate and a dimethyl sulfoxide solvate.4 Theophylline form
II is a metastable polymorph crystallized from most non-
aqueous solution at room temperature. It is kinetically stable
and was historically considered as the thermodynamically
stable polymorph, until form IV was presented5 and proved
to be more stable. The fact that the thermodynamically stable
theophylline polymorph was discovered only recently, is
because it does not crystallize directly from solution, and is
obtained only by slow, solvent mediated transformation
(SMPT) from form II in contact with solvent e.g. methanol,
2-propanol or chloroform.5 Theophylline form I has been
reported as the stable polymorph at higher temperatures,
whereas form III is highly metastable and has been obtained
only during the dehydration of monohydrate.6,7 Theophylline
monohydrate (referred to as form M) is a monoclinic channel, 2015, 17, 5237–5251 | 5237
ophylline (3,7 dihydro-1,3-
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View Article Onlinetype hydrate which has been shown to lose water, either in
low humidity or at temperatures above 353 K, to produce
form II.8,9 Theophylline has been screened for cocrystallization
and shown to produce co-crystals with a range of coformers;
many complexes formed between theophylline and acids (e.g.
oxalic acid, malonic acid, salicylic acid, sulfathiazole, acet-
aminophen, etc.) as well as bases (e.g. urea, benzylamine, phe-
nobarbital, etc.) have been summarized by Childs et al.10
The aim of this work is to understand why the thermody-
namically stable theophylline form IV can be obtained only
by solvent mediated transformation in specific solvents, and
to investigate the presence of prenucleation aggregates which
direct the polymorphic outcome of crystallization.
Hunter et al.11–13 and Davey et al.14,15 have shown that there
is a correlation between supramolecular aggregates in solution
and the solid state structure which subsequently crystallizes.
Early experiments16–19 on theophylline self-association provide
evidence that theophylline does self-associate in aqueous solu-
tion and the proposed aggregate is the theophylline dimer. The
theophylline dimer discussed in these studies is present in the
thermodynamically stable form IV, and theophylline mono-
hydrate, form M, which crystallizes from aqueous solutions.
Theophylline form II, the polymorph commonly crystallized
frommost non-aqueous solutions, does not contain this dimer
motif (crystal structures of theophylline polymorphs are
discussed in detail in section 2.1). Such behaviour raises two
questions: why does metastable form II crystallize from non-
aqueous solvents; what prenucleation aggregates are present in
non-aqueous solvents? In order to answer these questions, we
need to determine (a) does theophylline self-associate in other
solvents besides water, and, if it does, what is the nature of the
association, and (b) since the nucleation of form IV is kineti-
cally slow, does solution aggregation change over time?
2. Background
2.1. Polymorphism of theophylline
Crystal structures of theophylline crystalline forms relevant
for this research are shown in Fig. 1. In the form II structure5238 | CrystEngComm, 2015, 17, 5237–5251
Fig. 1 Crystal packing motifs in theophylline form II, form IV, theophyllinethe best hydrogen bond donor (N7–H) bonds to the best
hydrogen bond acceptor (N9),20,21 consistent with Etter's
rules,22 forming an R22(8) motif. The structure has two weak,
bifurcated C8–H⋯O13 hydrogen bonds. Theophylline mole-
cules are linked in chains and stacked along (010). This
catemer arrangement promotes crystal growth along the
molecular chains leading to an elongated crystal morphology.
Form IV has two molecules in its asymmetric unit,23 forming
a dimer with the R22(10) motif and connected via
(N7–H⋯O13) hydrogen bonds. The dimer is discrete and
only links to other dimers by weak interactions: C8–H⋯N9,
C8–H⋯O11, and by π–π stacking, forming a two-dimensional
network parallel to the (001). The dimer is similar to the
motif observed in the monohydrate and in a number of the-
ophylline cocrystals.10,21 The presence of this dimer motif in
the thermodynamically stable form IV and theophylline
monohydrate, considered to be the most stable structure in
an aqueous environment, may account for the thermody-
namic stability of this structural motif compared to the chain
motif of form II. In form M, two centrosymmetrically related
theophylline molecules form a dimer through two hydrogen
bonds (N7–H⋯O13).24 Theophylline dimers are connected by
water molecules through hydrogen bonds, forming parallel,
crosslinked chains, leading to two-dimensional hydrogen
bonded layers, parallel to (10−1) plane. Water molecules are
situated in channels along the a axis, where they form hydro-
gen bonds to the theophylline N9 atom. In theophylline
dimethyl sulfoxide solvate theophylline is hydrogen bonded
to the dimethyl sulfoxide molecule through an N7–H⋯OS
hydrogen bond.4 The packing consists of molecular chains
lying parallel to the (010), stacked by π–π interaction between
pyrimidine and imidazole rings, and weak hydrogen bonds
between dimethyl sulfoxide methyl groups and theophylline
carbonyl group (CDMSO–H⋯O13).
2.2. Solvent mediated phase transformations
Solvent mediated phase transformations (SMPTs) are com-
mon in polymorphic materials which often follow Ostwald's
rule of stages.25 The transformation proceeds by three stages:This journal is © The Royal Society of Chemistry 2015
monohydrate and DMSO solvate.
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View Article Onlinefirstly, the metastable polymorph in contact with solution
dissolves into the bulk. Secondly, the stable form nucleates,
and thirdly undergoes crystal growth. When complete, only
the stable form remains in solution. The thermodynamic
driving force is the Gibbs free energy difference between the
two solid structures, whereas the kinetic driving force is the
difference in the solubilities of the two polymorphs and thus
the level of supersaturation with respect to the stable
form.26–30
SMPTs are characterized by the phase transformation
time, induction time, and active phase transformation time.
The term “phase transformation” refers to the whole process
from the beginning of the experiment until the phase trans-
formation is complete; the initial period during which no
phase transformation product is observed is called “induc-
tion”; and the time from the point when thermodynamically
stable phase appears until the sample has been fully
converted is called the “active transformation phase”.31 All of
these parameters can be influenced by choice of solvent and
solution composition.2.3. Spectroscopic self-association studies
NMR spectroscopy is mainly used as a method for organic
compound identification and characterization; however NMR
methods have been demonstrated to be useful for the study
of molecular aggregation and self-association in solution. It
is possible to use solution NMR measurements to study
molecular association because 1H chemical shifts are sensi-
tive to changes in the local environment. Hydrogen bonding
between solute molecules and associate formation affects the
1H local environment and a result of this interaction is a
chemical shift displacement in the NMR spectrum.32–34
It is generally recognized that dimer and other associate
formation and their concentration are affected by solution
concentration – the more concentrated the solution, the more
dimers and other associates are present, therefore depen-
dence of 1H chemical shifts on concentration is analysed.
This approach has been used in numerous studies.35–44 Most
of the previous studies show a decrease in the 1H chemical
shifts with concentration increase, suggesting that the
analysed compounds are involved in self-association pro-
cesses. Upon self-association, 1H chemical shifts are
displaced to lower field due to proton deshielding – the bond
of the proton involved in self-association weakens, bond
length increases, stretching frequency decreases.45–49 The
limitations for 1H NMR self-association studies are that 1H
NMR shifts for nonexchangeable hydrogens only can be mea-
sured, and the NMR method has a limited sensitivity at the
low concentrations often necessary for initial self-association
studies.
In recent years, 1H NMR chemical shift displacement mea-
surements have been used to provide information on the
structure of prenucleation aggregates in the solution.50
Hunter et al.13,51 showed that the predictions from
concentration-dependent changes in 1H NMR chemical shiftsThis journal is © The Royal Society of Chemistry 2015agreed with the structures of dimers found in the corre-
sponding X-ray crystal structures.
Other magnetically active nuclei (13C, 15N and others)
involved in hydrogen bonding or aromatic stacking also show
displacement in chemical shifts upon concentration
changes.35,52–55
Theophylline self-association in aqueous solution has
been previously studied using NMR spectroscopy,17,18
partitioning between water and chloroform–isooctane mix-
ture,19 analytical ultracentrifuge;16 and in chloroform-D solu-
tion using IR spectroscopy.56 These studies suggest that the-
ophylline does self-associate in aqueous solutions and
chloroform-D solution; however there is no consensus
between these studies on the degree of self-association and
nature of aggregates present in the solution.
3. Results and discussion
3.1. Characterisation of solvent mediated phase
transformation
The SMPT of unprocessed commercial anhydrous theophyl-
line form II in methanol was investigated. Three parallel
experiments were performed, but for the sake of clarity only
one case is taken as an example of the whole set of experi-
ments to describe and discuss in detail the results obtained.
During the solvent mediated phase transformation quali-
tative and quantitative analysis of the solid phase were
performed using powder X-ray diffractometry (PXRD), Fourier
transform infrared spectroscopy (FTIR) and scanning electron
microscopy (SEM) methods; while the solution concentration
throughout the transformation was monitored using
ultraviolet-visible (UV/Vis) spectroscopy. The composition of
solid phase determined by PXRD method and solution con-
centration throughout SMPT is presented in Fig. 2. Results of
all three parallel experiments showed that the phase transfor-
mation from theophylline form II to form IV took ~6 to
8 days. Phase transformation had a considerable induction
time with a relatively high dispersion (4 to 6 days), while
the active phase transition (actual form IV increase in the
sample) consistently took ~2 days. Such behaviour, that
induction time for parallel experiments had a great variation,
while the active phase transition time in all cases was approx-
imately the same, suggests that the limiting step for this
SMPT is the nucleation of form IV. The main factors that
might affect the nucleation and hence the induction time are
discussed further.
The equilibrium saturation of the metastable form II was
reached ~3 h after the theophylline addition to methanol.
The concentration of the solution remained the same until
phase transformation was completed. Solution concentration
dropped to the equilibrium saturation of the thermodynami-
cally stable form IV within a few hours of the phase transfor-
mation being completed, indicating that, once all of the form
II in the sample had dissolved, form IV continued to grow
until the solution reached the form IV equilibrium concentra-
tion. This shows that the dissolution rate of theophyllineCrystEngComm, 2015, 17, 5237–5251 | 5239
Fig. 2 Solution concentration (●), and weight fraction of the
theophylline form IV in the solid phase (○) during the solution
mediated transformation from theophylline form II to form IV in
methanol at 23 °C. The dashed line (—) represents the solubility of
theophylline form II, continuous line (—) – solubility of theophylline
form IV.
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View Article Onlineform II was faster than the growth of form IV and dissolution
was not the limiting step in the phase transformation. Such a
solution concentration profile and pronounced induction
period indicates that the SMPT was a ‘nucleation-growth con-
trolled polymorphic transformation’.57 The fact that phase
transformation is also growth limited was confirmed by the
time scale of the studied SMPT – most of the SMPTs
described in the literature take place within a few
hours,29,57–65 but here phase transformation took ~2 days
from the moment when form IV nucleated. This might be
due to low supersaturation, which provided the necessary5240 | CrystEngComm, 2015, 17, 5237–5251
Fig. 3 SEM images throughout SMPT from theophylline form II to form I
scale bar, crystals of theophylline form IV indicated with blue colour.driving force to overcome the energy barrier and promoted
form IV crystallization.3 In this case, supersaturation is the
difference between the solubilities of form II and form IV.
The increase of the form IV content in the sample
exhibited an exponential nature – the amount of form IV
increased slowly in the initial stage and then accelerated.
Such behaviour suggests that the growth of form IV might be
limited by the surface area of form IV in the sample; hence,
the rate of SMPT increased as the crystal size (surface area)
in the sample increased. This assumption was consistent
with SEM imaging data, shown in Fig. 3.
It is known5 that theophylline form II exhibits a needle-
like morphology, while form IV crystallizes in hexagonal
plate-like crystals. These distinct differences in the crystal
shape allowed phase transition monitoring using microscopy
methods. SEM imaging of the solid phase throughout SMPT
(Fig. 3) revealed that during the first days, while no phase
transformation was observed, the only apparent change in
the solid phase was the agitation and Ostwald's ripening of
the theophylline form II crystals – small theophylline form II
crystals dissolved as growth occurred on the larger form II
crystal side planes (see Fig. 3, day 1 and day 3). Thus, larger
theophylline form II crystals grew at the expense of the small
particles. The reason for this process was the difference in
dissolution rate between small and large particles.66 Theoph-
ylline form IV crystals were first observed after 5 days, and all
observed hexagonal form IV crystals were approximately the
same size: ~40 μm in diameter and 1–2 μm thick. A similar
size for all observed form IV crystals suggests that they nucle-
ated simultaneously or in a very short time interval. Recent
studies60,65,67,68 show that surface nucleation dominates in
most of SMPTs, however in our case there was no clear evi-
dence of such behaviour. We believe that theophylline form
IV nucleated by homogeneous primary nucleation from satu-
rated solution because none of the observed form IV crystals
were clearly merged together with metastable form II.This journal is © The Royal Society of Chemistry 2015
V in methanol at 23 °C. Inset: time of sample gathering (days); 40 μm
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View Article OnlineMoreover, taking in to account that theophylline form IV
nucleated only after several days, homogeneous nucleation is
more likely as heterogeneous nucleation usually takes place
in shorter time scale due to lower energy barrier. Over time
form IV crystals grew significantly in 2 dimensions, forming
large, plate-like crystals. This growth pattern indicates that
the growth of the form IV was governed by the surface of the
crystal edges. Eventually, breakage of form IV crystals was
observed (day 6), which would lead to increased surface area
of the edge faces, where crystal growth was fastest, thereby
accelerating the crystallization rate of form IV.
Preferred form IV crystal growth directions were deter-
mined by the PXRD method. It is observed that the PXRD
pattern of form IV crystals after the SMPT have two very
intensive peaks at 12 and 23° 2θ (Fig. 4), suggesting that the
sample exhibits preferred orientation. Comparison of the pat-
tern with that simulated from the crystal structure revealed
that these intensive diffraction peaks arise from crystal
planes (002) and (004) – the multiple planes of the {001} face
family. Since plate-like crystals tend to lay down with the
dominant faces parallel to the PXRD sample holder, the most
intense diffraction should occur from this plane. It can there-
fore be concluded that the dominant face in the form IV crys-
tals obtained during SMPT is (001) and crystal growth
occurred almost exclusively along this plane. The reason for
such crystal growth behaviour is that there are no significant
intermolecular interactions in the c-direction of theophylline
form IV, whereas crystal growth along (001) plane is favoured
by hydrogen bonding and π–π stacking (Fig. 5).
Based on morphological observation, form IV crystal
growth perpendicular to (001) was observed only when phase
transformation was finished – during the SMPT the surfaces
of form IV crystal plane (001) were flat (Fig. 3, day 8.3),
whereas 2 days after the SMPT elevations on the surface ofThis journal is © The Royal Society of Chemistry 2015
Fig. 4 PXRD patterns of form IV obtained by SMPT inmethanol (solid line);
and simulated from crystal structure (dashed line).the form IV were observed because of crystal agitation (Fig. 3,
day 10). The crystal growth rate along (001) was considerably
higher than growth rate perpendicular to (001) during phase
transformation, likely to be because energy released on solu-
tion molecule attachment to growing crystal edge surface was
higher.69 When phase transformation was complete,
Ostwald's ripening66 took place and crystals tended to
achieve minimum total surface energy by reducing the crystal
surface area. Here, this means that crystals grew perpendicu-
lar to the large (001) plane at the expense of the crystal edges,
which dissolved more easily.66
Surface nucleation dominates in the majority of SMPTs,
therefore experiments with ground and lyophilized theophyl-
line as a starting material were performed to evaluate the
effect of the form II surface on the nucleation and crystalliza-
tion of form IV. There were no significant differences in the
phase transformation behaviour when ground and unground
theophylline was used. PXRD and SEM data showed that
when the ground form II was agitated, Ostwald's ripening
took place, and crystallization of form IV followed only after
6 days. If theophylline form IV nucleated on the surface of
the form II, the increase of the form II surface area in the
ground sample should reduce the induction time. However,
this was not observed, suggesting that form IV did not nucle-
ate on the surface of form II. When lyophilized theophylline,
confirmed as a mixture of amorphous theophylline and
microcrystalline form II, was used, no phase transition to
form IV was observed within the studied time (90 days). The
crystallinity of lyophilized material increased due to transfor-
mation of amorphous material to form II (Fig. 6), but no
phase transformation to form IV was detected. It is not clear
why crystallinity of the form II starting material should influ-
ence the nucleation of form IV since this is not a surface
nucleation process. Later experiments on water content (see
below) indicate that the ability of amorphous material to
absorb water might be more important than crystallinity.
In order to ascertain whether theophylline aggregates
present in the methanol solution affect the phase transforma-
tion, an experiment using methanol solution saturated with
respect to form IV as a solution medium was performed. The
SMPT held approximately the same induction and active
phase transformation time (5 and 2 days, respectively) as
experiments in methanol.
Similar experiments with theophylline form II and form IV
mixture ĲwII/wIV; 90/10) as a starting material were performed
to exclude induction time and observe only phaseCrystEngComm, 2015, 17, 5237–5251 | 5241
Fig. 5 Crystal packing in theophylline form IV along (001) plane.
Hydrogens are omitted for clarity.
Fig. 6 SEM images throughout lyophilized theophylline slurrying in
methanol at 23 °C. Inset: time of sample gathering (days) and 20 μm
scale bar.
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View Article Onlinetransformation. No induction times were observed in either
case, and phase transformation rates were the same regard-
less of solution composition (Fig. 7). This means the molecu-
lar aggregates, if there were any at all, in both saturated solu-
tions were the same and/or they did not play a significant
role in the phase transformation. If we compare theophylline
form IV weight fraction change over the time in these experi-
ments and those performed with commercial form II as a
starting material, we see that active phase transformation
with theophylline form II and IV mixture as a starting mate-
rial occurs three times faster. It is possible that this phase
transformation rate mismatch is due to differences in the
form IV crystal active edge surface areas for the samples.
SEM imaging confirmed that form IV edge surface area in
prepared polymorphic mixtures were larger, than in the sam-
ple where the same amount of form IV was generated by
SMPT. Since this is the region in which growth of form IV
dominates, larger surface area leads to faster rate of growth,5242 | CrystEngComm, 2015, 17, 5237–5251
Fig. 7 Weight fraction of the theophylline form IV in the SMPT from
theophylline form II/form IV mixture ĲwII/wIV; 90/10) to form IV, in
saturated (○) form IV and (●) form II methanol solutions at 23 °C. Δ
represents the weight fraction of the theophylline form IV in the solid
phase during the SMPT from theophylline form II in methanol at 23 °C.
All kinetic curves are aligned to the point when solid phase of
respective SMPT contained 10% of form IV.therefore a faster transformation. It is also possible that in
the studied SMPT the initial nucleation is homogeneous, but,
once form IV is present, then secondary nucleation may sub-
sequently occur, leading to increasing transformation rate as
observed. By seeding with form IV in this experiment, the ini-
tial phase was skipped and form IV nucleated by secondary
nucleation. Secondary nucleation promoted faster phase
transformation by detachment of weak outgrowths of form IV
seed crystals or fragmentation of a weak polycrystalline form
IV mass.66
Seton et al.5 reported that theophylline equilibrium solid
phase depends on the water activity in the solution, and that
form IV is preferred when water activity in the solution is
below 0.69 ĲVMeOH/VH2O, 55/45). To investigate the possibility
that water activity also influences the phase transformation
rate to form IV, SMPT was observed in methanol samples
with different water contents. SMPT from theophylline form
II to form IV, performed in dried methanol and methanol/
water mixtures with volume ratios ĲVMeOH/VH2O) 99 : 1, 95 : 5
and 80 : 20, clearly showed that increased water in the solu-
tion increased the induction time (Fig. 8A). Given the sto-
chastic nature of nucleation, it can be difficult to draw con-
clusions from a few experiments, however, the three parallel
SMPT showed relatively good reproducibility and a clear
trend. Active phase transformation time also increased but
with a lesser effect – from 1.5 days in dried methanol to 5
days in methanol/water mixture ĲVMeOH/VH2O; 95/5).
These results might explain why fluctuation of induction
time were observed in the earlier SMPTs. Methanol used in
initial experiments was used as received and was taken from
different batches, therefore the water content (adsorbed from
the air) was not the same in all samples. Karl Fisher titration
showed that batch methanol contained ~0.2% of water,
whereas methanol dried with anhydrous NaSO4 contained
less than 0.1% water. These minor water impurities affected
the induction time of the SMPT. This might be the reason
why phase transformation with lyophilized theophylline as
starting material was hindered. Theophylline lyophilisation
resulted in partially amorphous theophylline, which tends to
absorb more water from the air than crystalline phases,70
and it is possible that the phase transition in this case was
slowed down by adsorbed water.
The induction times and transformation times in a range
of solvents were measured and compared (Fig. 8B). We see
that phase transition times correlated to induction times –
the longer the induction time, the slower the phase transfor-
mation. This might indicate that nucleation and form IV
growth were limited by the same factors. The solvents were
used as received and were from newly opened bottles. Water
doping experiments were not performed in the other sol-
vents, so further investigation would show whether induction
and transformation times were similarly affected in all
solvents.
It has been shown previously30 that in the nucleation-
growth controlled SMPT between α and β tegafur, the phase
transformation rate and induction time linearly depends onThis journal is © The Royal Society of Chemistry 2015
Fig. 8 Induction and phase transformation times of SMPT from theophylline form II to form IV at 23 °C depending on used solvent environment.
No phase transformation to form IV was observed in formic acid and methanol/water mixtures with 5% and 20% of water within the studied period
(40 days).
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View Article Onlinesupersaturation level, i.e. difference between solubilities of
the polymorphs. The difference in solubility of the two forms
in methanol is low, so supersaturation with respect to form
IV is always low. In formic acid, the solubility of form II is
high, (30 times that in methanol, see ESI†) which might
favour the metastable form according to Ostwald's rule.
Crystallization always gave form II, including crystalliza-
tion from solutions with form IV equilibrium concentration.
Even seeding with form IV, gave form II and form IV mixture.
Induction and phase transition times were longer in sol-
vents (solvent mixtures) which had good proton donor
groups. Fastest phase transformation and shortest induction
time were observed in dried methanol, followed by stock
methanol, acetonitrile and acetone. Longest induction times
were observed in proton donor solvents – chloroform and
formic acid, and previously discussed methanol/water mix-
tures. In fact, no form IV has been detected in formic acid
and methanol/water mixtures 95/5 and 80/20 within the stud-
ied period of 90 days. An influencing factor might be behav-
iour of solvated/aggregated theophylline molecules in solu-
tion. Theophylline molecules are solvated in the solution, but
in order to nucleate form IV and continue its growth, theoph-
ylline molecules have to be desolvated, and solvent molecules
on the nuclei or crystal surface be replaced by incoming
theophylline molecules. Taking in to account that induction
time was several days and phase transformation was very
slow, we can assume that solute–solvent interaction in stud-
ied SMPT was strong compared to solute–solute interaction
and thus the desolvation process inhibited form IV nucle-
ation and growth.
In order to further understand how the solvent environ-
ment affects SMPT rate and induction time, NMR spectro-
scopy was used to investigate for prenucleation aggregates in
the solution.3.2. Theophylline self-association studies
To understand solution chemistry and ascertain possible
aggregation of theophylline molecules in solution, theThis journal is © The Royal Society of Chemistry 2015influence of theophylline solution concentration on 1H NMR
chemical shift displacement was analysed. 1H NMR experi-
ments were carried out in seven solvents (methanol-D4,
chloroform-D, acetone-D6, dimethyl sulfoxide-D6, deuterium
oxide, acetonitrile-D3 and formic acid-D2). These solvents
were chosen because: (a) it is known that in dimethyl sulfox-
ide and water theophylline crystallizes as solvates and the
crystal structures of these solvates are not similar; (b) they
have different H-bond donor/acceptor properties: acetone,
acetonitrile and dimethyl sulfoxide are H-bond acceptor;
chloroform is H-bond donor; water, methanol and formic
acid are both – H-bond donor and acceptor; and (c) from
formic acid theophylline crystallizes into form II with no sub-
sequent transformation observed.
The concentration range covered in this experiment was
the same for all solvents – from saturated to 1 μM theophyl-
line form II solution. The number of scans for NMR spectra
acquisition was adjusted depending on solution concentra-
tion. Theophylline solutions with lower concentrations were
not studied because the NMR spectra acquisition time, neces-
sary to obtain spectra with acceptable signal/noise ratio,
would be unreasonably long.
The theophylline used in the experiment had natural 1H/2H
abundances and therefore the most acidic imidazolium group
proton (N7–H) took part in proton exchange with the deuter-
ated solvent deuterium atoms. As a result, the imidazolium
group proton was visible in the NMR spectra in solvents where
only partial proton exchange took place – chloroform-D,
dimethyl sulfoxide-D6 and acetonitrile-D3. Methyl group pro-
tons and alkene group proton (C8–H) did not showed any effect
on proton exchange.
If there are multiple structures that have different thermo-
dynamic stabilities and perturb the 1H NMR chemical shifts
in different ways, the shapes of the dilution curves differ for
different signals. While this does not rule out the possibility
of multiple structures, the data can be treated as a simple
two state equilibrium, and the complexation-induced changes
in chemical shift are assumed to relate to a single specific
aggregate structure.51 Since the solubility of the theophyllineCrystEngComm, 2015, 17, 5237–5251 | 5243
Fig. 10 Theophylline dimer present in crystal structures of
monohydrate, form IV and most cocrystals (A); and the preferred
theophylline dimer according to Etter’s rules (B).
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View Article Onlinein all selected solvents except formic acid is low (>0.06 M)
multiple aggregate structures are not expected.
No chemical shift displacement upon concentration
changes were observed in methanol-D4, acetone-D6, dimethyl
sulfoxide-D6 and acetonitrile-D3. This means that no self-
association takes place in these solvents, or theophylline
undergoes dimerization or other self-association at concen-
trations lower than those covered in the experiment, i.e.
below 1 μM, and other agglomerates do not form in the con-
centration region studied. It is unlikely that self-association
occurs at such low concentrations, and it is probable that sol-
vated theophylline monomers were the main species in the
solution.
1H NMR dilution studies in chloroform-D, deuterium
oxide and formic acid-D2 showed large concentration-
dependent changes in chemical shifts. In the chloroform-D
all chemical shifts were displaced to lower fields as concen-
tration increased (Fig. 9A). In deuterium oxide methyl groups
1H chemical shifts were displaced to higher field while the
alkene group proton (C8–H) chemical shift was displaced to
the lower field (Fig. 9B). Imidazolium group proton (N7–H)
chemical shift was not observed in the deuterium oxide due
to proton exchange. In formic acid-D2 alkene group proton
(C8–H) chemical shift was displaced to higher field, whereas
imidazolium group proton (N7–H) chemical shift was
displaced to lower field (Fig. 9C). Minor methyl groups 1H
chemical shift displacement to higher and field were
observed as concentration increased. The pattern and magni-
tude of chemical shift changes are completely different in all
solvents, indicating that aggregates present in these solutions
are different. It is likely the associate existing in the deute-
rium oxide is the theophylline dimer which is also present in
the crystal structure of theophylline monohydrate (Fig. 10A).
The associates in chloroform-D solution might be the asym-
metric dimer corresponding to Etter’s rule (Fig. 10B), π–π
stacked dimer or some associate involving solvent molecules.
It is also possible, that chemical shift displacement is
reflecting the average structure of multiple aggregates. Since
theophylline solubility in formic acid is noticeably higher
than in other solvents (more than 30 times), it is possible5244 | CrystEngComm, 2015, 17, 5237–5251
Fig. 9 Theophylline chemical shift displacement depending on chlorofor
Chemical shifts are indicated as: methyl group C10 protons (●); methyl gr
group proton (N7–H) (▲).that associates present in formic acid-D2 were oligomers and
not dimers. Data shows that theophylline concentration at
which associates were formed were different in each solvent.
In deuterium oxide theophylline formed self-associates at
10−4 M solution, in chloroform at 10−3 M solution, and in
formic acid-D2 at 10−2 M solution.
No change in chemical shift displacement was observed
with time (>20 days) in any studied solvents. Small scale
SMPT performed in methanol-D4 showed the same – solution
composition did not change over time; hence, no aggregates
are formed or disarranged during slurrying indicating that
this is not the reason for long induction times.
Theophylline aggregates formed in solvents which are
good proton donors.71 These were the solvents where SMPT
exhibited longest induction times and phase transition rates
(we should mention that SMPT in water does not occur,
because theophylline monohydrate is the most stable crystal-
line form in aqueous environments). Such correlation implies
that the presence of theophylline dimers or aggregates in the
solution hinders the nucleation and growth of form IV. It is
likely that the reason why good proton donors inhibit phase
transformation and extend induction time is the formation
of solvent molecule stabilized theophylline aggregates. Trask
et al.21 have suggested that the theophylline dimer motif is
favoured by the presence of a competing strong hydrogen
bond donor in the system (in this case formic acid, chloro-
form or water in methanol/water mixture). The strongest
hydrogen bond donor in theophylline solution forms aThis journal is © The Royal Society of Chemistry 2015
m-D (A); deuterium oxide (B); and formic acid-D2 (C) concentration.
oup C12 protons (○); alkene group proton (C8–H) (Δ); and imidazolium
Fig. 11 FTIR spectra of theophylline form II (solid line) and form IV
(dashed line), showing carbonyl group, alkene group hydrogen bond
and imidazolium group hydrogen bond stretching band assignment.
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View Article Onlinehydrogen bond with the system's most basic group – theoph-
ylline imidazole group nitrogen (N9). This bond fulfils the
‘best-donor–best-acceptor’ rule and consequently permits
theophylline dimer formation by secondary hydrogen bond-
ing (N7–H⋯O13). Such solvated theophylline dimer should
be the most stable aggregate in the solution, since it uses the
system's best donors and acceptors. This explains why
increasing water in the methanol sample increased induction
time and extended phase transformation time. The increase
of water in methanol/water mixture increased the level of
hydrated aggregates in the solution, and the more solution
theophylline molecules were bound in these dimers, the
more formation of form IV was hindered.
Solvated theophylline aggregates inhibit nucleation and
growth of form IV, either because they are not the correct
structure to nucleate form IV or because these associates
need to be desolvated or disarranged in order to crystallize. If
the solute solvent bonds are stronger than the weak inter
dimer interactions in the solid structure, then the desolvation
process is unfavourable and therefore phase transition is
slow. Recent work by Sullivan et al.72 shows that desolvation
is a significant factor in the nucleation process and can dom-
inate nucleation kinetics.3.3. FTIR studies of theophylline crystallization from
saturated solutions
It is known2,3,73–75 that FTIR spectra of polymorphs and their
solutions are different. Parveen et al.76 have shown that FTIR
spectroscopy can be used to show a direct relationship
between molecular self-associates in solution and motifs in
the subsequently crystallized solid phases. Here we use FTIR
spectroscopy to monitor theophylline crystallization from ace-
tone, acetonitrile, chloroform, methanol and water. FTIR
spectra of saturated theophylline solution were continuously
recorded during solvent evaporation and subsequent theoph-
ylline crystallization. FTIR spectra of both theophylline
polymorphs studied in this work are clearly different and
therefore suitable for such an experiment (Fig. 11). However,
due to low theophylline solubility in the selected solvents,
only the strongest carbonyl group stretching bands were visi-
ble in the initial spectra.
It is known77 that hydrogen bonding lengthens and
weakens the CO bond, therefore the carbonyl group
stretching band is observed at a lower frequency; thus the
stronger the hydrogen bonding, the lower the stretching fre-
quency. FTIR can be used to show hydrogen bonding of the
carbonyl group.78 This rule can be clearly seen in the case of
theophylline. Carbonyl group C2O11, which is not involved
in the hydrogen bonding in either polymorph (there are only
weak interactions with theophylline methyl group hydro-
gens), has an identical band position in the FTIR spectra
(1706 cm−1) and the stretching frequency is higher than that
of C6O13 carbonyl group. In form IV, the carbonyl group
C6O13 is involved in strong hydrogen bonding with the best
hydrogen bond donor (N7–H) and this results in a stretchingThis journal is © The Royal Society of Chemistry 2015frequency of 1640 cm−1; while in form II, the C6O13 group is
involved in two weak bifurcated C8–H⋯O13 hydrogen bonds,
stretching band is observed at 1664 cm−1.
Fig. 12 illustrates the carbonyl group stretching band posi-
tion and intensity changes during theophylline crystallization
from saturated form II solutions during solvent evaporation.
The stretching bands of other groups/bonds expected to
take part in self-association – alkene group hydrogen bond
and imidazolium group hydrogen bond – were not visible in
solution FTIR spectra due to low theophylline solubility in
the chosen solvents, and they were observed only when all
the solvent had evaporated. During the solvent evaporation
the intensities of all theophylline bands increased because of
increasing theophylline concentration in the solution. An
exception to this was the final part of crystallization from sat-
urated methanol solution, where theophylline carbonyl group
intensities decreased. For clarity these spectra are shifted by
y axis. Crystallization from acetone, acetonitrile, chloroform,
methanol and formic acid gave theophylline form II, and
water produced theophylline monohydrate. Intensive water
OH bending band was overlapping with both theophylline
carbonyl group stretching bands, therefore the crystallization
experiment from saturated water solution was not suitable
for studies.
The strongest carbonyl group stretching bands in theoph-
ylline solution spectra were observed in concentrated solu-
tion, whereas weaker spectral bands appeared only when the-
ophylline crystals emerged. In all solvents the most distinct
changes in theophylline band positions and intensities were
observed at the moment when solid theophylline emerged.
This was due to fact that, before the crystallization FTIR spec-
tra represented mostly solvated theophylline and theophyl-
line associates, whereas during the crystallization, spectra
were reflecting the average spectra of solvated theophylline,
multiple theophylline associates and crystalline theophylline.
The ratio of these species changed during the evaporation/CrystEngComm, 2015, 17, 5237–5251 | 5245
Fig. 12 FTIR spectra of carbonyl group stretching band region during theophylline crystallization from saturated solutions upon solvent
evaporation at room temperature. Colour gradient shows FTIR spectra changes throughout crystallization (red – saturated solution, blue –
crystallization product). FTIR spectra of solid theophylline form II (dashed line) and IV (continuous line) are added for comparison purpose.
Acetone carbonyl group stretching band is marked with ▲.
CrystEngCommPaper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
7 
Fe
br
ua
ry
 2
01
5.
 D
ow
nl
oa
de
d 
on
 1
9/
08
/2
01
5 
11
:4
9:
35
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinecrystallization and therefore, the band position of functional
groups involved in these processes also changed. Finally,
when all solvent have evaporated, FTIR spectra of crystalline
theophylline was observed.
The position of C2O11 carbonyl group stretching band
in methanol, acetonitrile and chloroform solutions were the
same (1706 cm−1) and it coincided with the position of this
group in both polymorphs, therefore we can conclude that
this group was not involved in strong hydrogen bonding in
the solution (similar to crystalline theophylline) and the
nearby environment of this group was similar to that in both
polymorphs. The position of this stretching band in acetone
solution cannot be determined, as acetone carbonyl group
stretching bands overlaps with this carbonyl group stretching
band. The position of C2O11 carbonyl group stretching
band does not change during the crystallization from metha-
nol solution, whereas during the crystallization from acetoni-
trile and chloroform solutions the band shifted to 1720 cm−1
indicating a change in bonding. The final position of this
group stretching band does not match that in the solid form
II. FTIR spectra did not change within 5 h. Such band shift
to higher frequency indicates that hydrogen bonding was
weaker in the crystallized material than in solution. Crystalli-
zations from both solvents were repeated in larger scale.
PXRD showed that crystallization products were form II, and
FTIR spectra of obtained material coincided with form II
spectra. The reason why C2O11 carbonyl group stretching
band position in FTIR in situ experiment does not match the
position of this band in form II spectra might be related to
theophylline crystallization manner from acetonitrile and5246 | CrystEngComm, 2015, 17, 5237–5251chloroform. No distinct theophylline crystals were observed
on the FTIR spectrometer liquids plate after solvent evapora-
tion, meaning that theophylline crystallized as a thin film.
Such crystallization behaviour might promote monolayer
product along (100) plane, where this carbonyl group is on
the surface and it is not involved in any hydrogen bonding.
Consequently, C2O11 carbonyl group stretching band
would be shifted to higher frequency for such crystallization
product.
In saturated formic acid solution position of C2O11 car-
bonyl group stretching band was 1696 cm−1 and during the
crystallization it gradually shifted to the position of this car-
bonyl group in crystalline theophylline. This happened
because in the solution this carbonyl group was involved in
hydrogen bonding with formic acid proton, whereas during
the crystallization this hydrogen bond was disarranged.
Unlike C2O11 carbonyl group, the position of the
C6O13 carbonyl group stretching bands were not the same
in the methanol solution and crystallized material (Fig. 12A).
In the methanol solution the carbonyl group C6O13
stretching band was observed at 1656 cm−1, i.e. in between
the stretching bands of this carbonyl group in solid form II
and form IV. This suggest that the associates (dimers, aggre-
gates, solvated entities) in the solution were not the same as
in the solid phases and that the hydrogen bonding in the
solution was stronger than that in the form II and weaker
than that in form IV. From 1H NMR experiment we know that
there was no theophylline self-association in methanol, there-
fore we can conclude that the association causing band shift
must be hydrogen bonding between the carbonyl group andThis journal is © The Royal Society of Chemistry 2015
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View Article Onlinemethanol –OH group proton. The changes of the C6O13
stretching band position were observed at the final part of
the crystallization and the band position shifted from 1656 to
1664 cm−1, which is the position of this band in theophylline
form II.
In chloroform, analogous C6O13 carbonyl group
stretching band shift were observed (Fig. 12D), with the only
difference that initially this band had two maxima – at 1656
cm−1 and 1648 cm−1. The band at 1656 cm−1 corresponds to
solvated theophylline species, analogous to those in metha-
nol, whereas the band at 1648 cm−1 most likely corresponds
to the dimer detected by NMR measurements. A similar situa-
tion was observed when theophylline crystallized from formic
acid; with the difference that in saturated formic acid solu-
tion a wide band in this region was observed. The wider car-
bonyl group stretching band must be a result of multiple
associates. The concentration of saturated formic acid solu-
tion was ~100 times higher than the concentration of satu-
rated chloroform solution, therefore it was expected that
associates formed were more complex than dimers and with
some diversity. Upon crystallization these agglomerates were
disarranged and desolvated, and the final position of
C6O13 carbonyl group stretching band matched the posi-
tion of form II.
Minor changes in the position of the C6O13 carbonyl
group stretching band were observed when theophylline crys-
tallized from acetone solution. This suggests that theophyl-
line hydrogen bonding did not change significantly upon
crystallization from acetone, at least as regards to this car-
bonyl group. The position of C6O13 carbonyl group
stretching band remained the same during the crystallization
from acetonitrile. Such behaviour points out, that this the-
ophylline carbonyl group does not form hydrogen bonds in
acetone and acetonitrile solutions, neither to solvent mole-
cules, nor to other theophylline molecules. It is understand-
able – acetone and acetonitrile are not proton donor solvents.
However it was expected that these solvents would compete
with the basic theophylline imidazole group nitrogen (N9) to
form a hydrogen bond with the most acidic theophylline pro-
ton (N7–H). NMR experiments showed that theophylline mol-
ecules in the acetone and acetonitrile solution are mono-
meric and self-association does not occur in these solvents,
meaning that species with solvated (N7–H) group dominated
in acetone and acetonitrile.
The same FTIR in situ crystallization experiment was
repeated with saturated form IV solution in methanol and
identical results were obtained, suggesting that there are the
same associates in the solution regardless of to which poly-
morph the solution is saturated.
4. Conclusions
The SMPT from theophylline form II to form IV is a very slow
nucleation-growth controlled polymorphic transformation.
Form IV nucleation is most likely homogenous and is slow.
Nucleation of and therefore induction of the phaseThis journal is © The Royal Society of Chemistry 2015transformation is hindered by solution aggregates. Form IV
crystals grow along the (001) direction, forming plate-like
crystals. SMPT induction times correlate to phase transition
times in studied solvents, indicating that nucleation and
form IV growth is limited by the same factors. Theophylline
forms associates in solvents which are good H-bond donors
i.e. chloroform, water and formic acid. There are the same
molecular aggregates in the solutions saturated with respect
to form II and form IV. The theophylline aggregates present
in solution do not change over time and therefore the long
induction time of form IV is not dependent on aggregation
kinetics. NMR and FTIR data suggest that the nature of
solution aggregates is solvent dependent, most likely linked
to hydrogen bonding character of the solvent.
5. Experimental section
5.1. Materials
Anhydrous theophylline was obtained from Sigma-Aldrich
and was certified >99% pure. Anhydrous theophylline was
confirmed to be form II and was used as received. Methanol
(HPLC grade), acetonitrile (HPLC grade), acetone (ARC grade)
and chloroform (HPLC grade) were obtained from Fischer
Scientific, formic acid (>98%) from Sigma-Aldrich. Solvents
were used without further purification. Distilled water was
used. Methanol-D4 (CD3OD, 99.8%), acetone-D6 Ĳ(CD3)2O,
99.9%), dimethyl sulfoxide-D6 Ĳ(CD3)2SO, 99.9%) and formic
acid-D2 (98%; <5% D2O) were obtained from Cambridge Iso-
tope Laboratories, deuterium oxide (D2O, 99.96%) from BDH
Chemicals, chloroform-D (CCl3D, 99.8%) from Euriso-top,
and acetonitrile-D3 (CD3CN, 99.8%) from Apollo Scientific.5.2. Preparation of theophylline crystalline forms
Theophylline form IV. Theophylline form IV was prepared
as described previously.5 An excess amount of anhydrous the-
ophylline (1.0 g) was added to 25 mL of methanol and stirred
at 600 rpm for 14 days at 23 ± 1 °C (temperature was con-
trolled because temperature deviations was found to hinder
form IV nucleation). The resulting solid phase was filtered
through a Buchner funnel under reduced pressure. The poly-
morphic form of the dry residue was confirmed using PXRD.
Theophylline form I. Anhydrous theophylline form II
(~1.0 g), was ground in a mortar with pestle for 3 min,
transferred to a petri dish, covered by a glass slide and
heated at 268 ± 1 °C for 2 h. The sample was cooled to
room temperature and the polymorphic form was confirmed
using PXRD.
Lyophilized (microcrystalline) theophylline. The excess
amount of anhydrous theophylline (~5.0 g) was added to
250 mL of water and was left to stir overnight. The solid phase
was removed by filtration and the remaining clear solution was
spray dried using a Buchi mini spray dryer B-290. A top spray
method was used with the inlet temperature set at 120 °C, the
outlet at 70 °C and the pressure at 6 bar. The crystallinity of the
material obtained was examined using PXRD.CrystEngComm, 2015, 17, 5237–5251 | 5247
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View Article OnlineTheophylline monohydrate. The excess amount (~3.0 g) of
anhydrous theophylline was dissolved in ~100 mL of warm
water (~70 °C) and was left to stir overnight. The precipitated
solid phase was filtered, air dried and the crystalline phase
obtained was confirmed using PXRD.
5.3. Examination of solution mediated phase transformation
An excess amount (2.5 g) of anhydrous theophylline form II
(used as received) was added to 100 mL of methanol. The
suspension was stirred at 600 rpm for 14 days at room tem-
perature (23 ± 1 °C) and the following measurements were
performed every 7 to 24 h.
(a) Solution concentration monitoring. Theophylline con-
centration in the solution was measured every 1 h to 1 day.
The solution (~1 mL) was filtered through a syringe filter of
0.20 μm size, and solution concentration was determined as
described in section 5.7. Three parallel solution concentra-
tion determination experiments were performed.
(b) Crystallization product from solution. 2 mL of the solu-
tion was filtered through 0.20 μm syringe filter, transferred
to a Petri dish and was left to evaporate at room temperature.
Crystallized dry residue of three parallel experiments was
combined and phase composition was examined using
PXRD.
(c) FTIR spectra of the solution. ~0.3 mL of the filtered
solution was gathered as described above, and the FTIR spec-
tra of solution were recorded immediately after sample
gathering.
(d) Phase composition of the solid phase. The stirring of
the slurry was stopped 30 seconds prior to sample gathering,
to allow the suspended solid particles to settle. Solid phase
sample (10–20 mg) was collected with a metal spoon from
the suspension and was quickly filtered through Buhner fun-
nel filter under reduced pressure. The solid phase was exam-
ined using PXRD, FTIR and SEM.
SMPT was repeated in triplicate.
SMPT was additionally performed with different starting
materials and solvents (given in Table 1). Single runs were5248 | CrystEngComm, 2015, 17, 5237–5251
Table 1 Starting materials and solvents used in SMPT
Starting material
Commercial form II
Form II, ground in mortar with pestle for 3 min
Lyophilized form IIa
Commercial form II
Commercial form II/form IVa mixture ĲwII/wIV; 90/10)
Commercial form II/form IVa mixture ĲwII/wIV; 90/10)
Commercial form II
Commercial form II
Commercial form II
Commercial form II
Commercial form II
Commercial form II
Commercial form II
Commercial form II
a Prepared as described in section 5.2. b Small scale experiment, Vtotal = 4performed for these experiments. The phase composition of
the solid phase was monitored every 1 to 7 days, except exper-
iments where form II and form IV mixture was used; the
phase composition in these experiments was monitored every
10 min to 1 h. The solvent and theophylline ratio in all SMPT
experiments were the same (2.5 g of theophylline and 100 mL
of solvent), except SMPT in formic acid, where 15.0 g of the-
ophylline were added to 25 ml of formic acid due to high the-
ophylline solubility in formic acid.
SMPT in methanol-D4 was performed for H1 NMR studies.
An excess amount (0.5 g) of commercial theophylline form II
was added to 4.0 mL of methanol-D. The suspension was
stirred at 600 rpm for 10 days at room temperature (23 ± 1 °C).
PXRD patterns of solid phase and solution H1 NMR spectra
(see section 5.9) were recorded each day. Stirring was
stopped 1 min prior to sample collection, and: (a) clear solu-
tion (~1 mL) was transferred to NMR tube; (b) solid phase
(10–20 mg) was collected with a metal spoon and quickly
filtered through a Buchner funnel filter under reduced
pressure. PXRD and H1 NMR measurements were performed
immediately after sample collection. Solution from NMR
experiment was returned back to the reaction vial immedi-
ately after recording the NMR spectrum.5.4. Determination of theophylline solubility
Theophylline form II solubility in acetone, acetonitrile, meth-
anol, chloroform and formic acid and form IV solubility in
methanol were determined as follows. An excess amount of
theophylline was added to 15 mL of solvent and was left to
stir overnight at 23 ± 1 °C. The saturated solution was filtered
through a 0.20 μm syringe filter and then 10.0 mL of clear
solution was transferred to a preweighed vial. Solution was
left to evaporate at room temperature, weighed and theophyl-
line solubility was calculated. The PXRD pattern of the filtrate
was recorded to ensure that the solubility of the desired poly-
morph was determined. Two parallel experiments were
performed.This journal is © The Royal Society of Chemistry 2015
Solvent
Methanol
Methanol
Methanol
Methanol saturated to theophylline form IV
Methanol saturated to theophylline form II
Methanol saturated to theophylline form IV
Methanol/water mixture ĲVMeOH/VH2O; 99/1)
Methanol/water mixture ĲVMeOH/VH2O; 95/5)
Methanol/water mixture ĲVMeOH/VH2O; 80/20)
Acetone
Acetonitrile
Chloroform
Formic acid
Methanol-D4b
.0 Ml.
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View Article Online5.5. Powder X-ray diffraction (PXRD)
Samples were analysed with a Rigaku Miniflex powder X-ray
diffractometer. Diffraction patterns within the 2θ range of 5°
to 40° were recorded at room temperature using Cu Kα radia-
tion at 1.54180 Å, with the following measurement condi-
tions: tube voltage 30 kV, tube current 15 mA, step-scan
mode with the step size 2θ = 0.02°, and the counting time
2 s per step. Diffractometer slits were set as follows: divergence
slit – variable; scattering slit – 4.2°, receiving slit – 0.3 mm.
Powder samples were packed into aluminium sample holders
and pressed by a glass slide to ensure co-planarity of the
powder surface with the surface of the holder.
Qualitative phase analysis. Reference powder patterns
were calculated with Mercury 3.3 (ref. 79) software from Cam-
bridge Structural Database (CSD) crystal structure data with
the reference codes BAPLOT for theophylline form II and
BAPLOT03 for theophylline form IV.
Quantitative phase analysis. The quantitative Rietveld
phase analysis were performed using BGMN software (version
1.8.6b)80 with Profex (version 3.1.1) interface. Crystal struc-
ture data previously mentioned were used for Rietveld
analysis.
5.6. FTIR spectroscopy
FTIR spectra were recorded using a Perkin-Elmer Spectrum
BX spectrometer fitted with a PIKE Technologies MIRacle
sampling accessory. MIRacle liquids plate was used when
spectra of solutions were recorded. The samples were
scanned at a resolution of 4 cm−1 between 4000 cm−1 and
600 cm−1. Each spectrum consisted of 16 co-added scans if
not otherwise stated.
5.7. UV/Vis spectroscopic solution concentration monitoring
Solution concentration throughout SPMTs in methanol was
monitored by measurements of the UV/Vis absorption at
272 nm using a Perkin-Elmer Lambda 25 UV/Vis spectropho-
tometer. Calibration was performed in the concentration
region between 0.2 mM and 0.01 mM (R2 = 0.99990). For
solution concentration determination 20 μL aliquot of fil-
tered reaction medium was diluted with 40 mL of methanol.
5.8. Scanning electron microscopy (SEM)
SEM imaging was performed using Inspect S SEM (FEI,
Holland) system. Samples were initially gold coated using a
K550X sputter coater (EMITECH, UK) and subsequently
scanned using an acceleration voltage of 5.0 kV at a working
distance of approximately 10 mm.
5.9. NMR spectroscopic self-association studies
1H NMR spectra were recorded as a function of theophylline
concentration in the solution. Experiments were performed
in methanol-D4, chloroform-D, acetone-D6, dimethyl sulfox-
ide-D6, deuterium oxide, acetonitrile-D3 and formic acid-D2
concentration region from nearly saturated solutions (1.0 MThis journal is © The Royal Society of Chemistry 2015in formic acid-D2, 0.050 M in methanol-D4, 0.015 M in ace-
tone-D6, 0.10 M in dimethyl sulfoxide-D6, deuterium oxide,
chloroform-D and acetonitrile-D3) to 1 μM solutions was cov-
ered. Ground anhydrous theophylline form II was used to
prepare the most concentrated solution in each solvent and
the rest of the solutions were prepared by subsequent dilu-
tion. Additional samples, where an excess amount of ground
theophylline was added to deuterated solvents, were prepared
to simulate suspensions similar to that examined in SMPT.
The mass of theophylline added was 120% of the mass neces-
sary to prepare saturated solution in the respective solvent.
An analytical balance (±0.1 mg) and micropipettes (±1 μL)
were used for solution preparation. NMR spectra of prepared
solutions were recorded right after solution preparation, and
repeated after 1 and 2 weeks. NMR tubes of prepared solu-
tions were closed with lids and sealed with parafilm. Samples
were stored at 20.0 ± 0.5 °C between measurements.
1H NMR spectra were recorded on a Bruker Avance
DRX 300 MHz spectrometer using residual solvent as an
internal standard. NMR spectra were recorded at 26.8 ± 0.5 °C
(300.0 ± 0.5 K).
Theophylline 1H chemical shifts were allocated by 1H-13C
HSQC according to literature assignments.81 1H-13C HSQC
experiments were carried out using the standard Bruker pro-
gram hsqcetgpsi2.82,83
5.10. In situ monitoring of crystallization process
Two drops (~0.07 mL) of saturated theophylline methanol,
acetone, acetonitrile, chloroform, water and formic acid solu-
tions from solubility determination experiments (section 5.4)
were placed on a FTIR spectrometer liquids plate and spectra
of the solution were continuously recorded during solvent
evaporation/theophylline crystallization. Each FTIR spectra
showed the average of 16 co-added scans, recorded in 75 s.
For acetone solution 4 co-added scans (recorded in 17 s) were
averaged. Spectra were recorded until three continuous spec-
tra were identical and no peaks of solvents were visible. The
experiment with each solvent was repeated in triplicate.
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